Prostate cancer survivors with symptoms of radiation cystitis have elevated fibrotic and vascular proteins in urine
Autor: | Laura E. Lamb, Bernadette M.M. Zwaans, Michael B. Chancellor, Heinz E. Nicolai |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_treatment 030232 urology & nephrology Cancer Treatment Urine Gastroenterology Prostate cancer 0302 clinical medicine Cancer Survivors Fibrosis Cystitis Medicine and Health Sciences Medicine Stage (cooking) Immune Response Multidisciplinary Proteinuria Prostate Cancer Bladder and Ureteric Disorders Prostate Diseases Middle Aged Oncology 030220 oncology & carcinogenesis medicine.symptom Anatomy Research Article Clinical Oncology medicine.medical_specialty Urology Bladder Science Immunology Radiation Therapy Inflammation 03 medical and health sciences Signs and Symptoms Diagnostic Medicine Internal medicine Cancer Detection and Diagnosis Humans Radiation Injuries business.industry Cancer Prostatic Neoplasms Cancers and Neoplasms Biology and Life Sciences Renal System medicine.disease Radiation therapy Genitourinary Tract Tumors Blood Vessels Clinical Medicine business Developmental Biology |
Zdroj: | PLoS ONE, Vol 15, Iss 10, p e0241388 (2020) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Radiation for pelvic cancers can result in severe bladder damage and radiation cystitis (RC), which is characterized by chronic inflammation, fibrosis, and vascular damage. RC development is poorly understood because bladder biopsies are difficult to obtain. The goal of this study is to gain understanding of molecular changes that drive radiation-induced cystitis in cancer survivors using urine samples from prostate cancer survivors with history of radiation therapy. 94 urine samples were collected from prostate cancer survivors with (n = 85) and without (n = 9) history of radiation therapy. 15 patients with radiation history were officially diagnosed with radiation cystitis. Levels of 47 different proteins were measured using Multiplex Luminex. Comparisons were made between non-irradiated and irradiated samples, and within irradiated samples based on radiation cystitis diagnosis, symptom scores or hematuria. Statistical analysis was performed using Welch's t-test. In prostate cancer survivors with history of radiation therapy, elevated levels of PAI 1, TIMP1, TIMP2, HGF and VEGF-A were detected in patients that received a radiation cystitis diagnosis. These proteins were also increased in patients suffering from hematuria or high symptom scores. No inflammatory proteins were detected in the urine, except in patients with gross hematuria and end stage radiation cystitis. Active fibrosis and vascular distress is detectable in the urine through elevated levels of associated proteins. Inflammation is only detected in urine of patients with end-stage radiation cystitis disease. These results suggest that fibrosis and vascular damage drive the development of radiation cystitis and could lead to the development of more targeted treatments. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |